TGF-β activity increased in MFAP2(−/−) adipose tissue, and treating MFAP2(−/−) mice with a TGF-β-neutralizing antibody improved their body temperature and prevented the increased obesity (89). Here, MFAP2 is linked to obesity due to melanocortin 4 receptor deficiency.